CONMED Corp
CNMD- Exchange
- NYSE
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0000816956
No open-market purchases or sales by CONMED Corp insiders were filed in the last 90 days; 246 institutions reported holding it in 13F filings for Q2 2026, worth $1.12B in total; no superinvestor holds it.
Holders of 5% or more of CNMD
Holders whose latest Schedule 13D or 13G filing reports 5% or more of CONMED Corp, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G/A | 15.10%4.68M shares | – | Jul 18, 20251 filing | Jul 18, 2025 | SEC |
| Vanguard Portfolio Management LLC | 13G | 6.87%2.12M shares | New | Apr 29, 20261 filing | Apr 29, 2026 | SEC |
| Fuller & Thaler Asset Management, Inc. | 13G | 5.63%1.74M shares | New | Aug 14, 20251 filing | Aug 14, 2025 | SEC |
| Vanguard Capital Management LLC | 13G | 5.25%1.62M shares | New | Apr 29, 20261 filing | Apr 29, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
27 Schedule 13D and 13G filings on CONMED Corp, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Apr 29, 20265:36 PM ET | Vanguard Capital Management LLC | 13G | 5.25%1.62M shares | New | Mar 31, 2026 | SEC |
| Apr 29, 202612:54 PM ET | Vanguard Portfolio Management LLC | 13G | 6.87%2.12M shares | New | Mar 31, 2026 | SEC |
| Mar 26, 20265:41 PM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | –Below 5% | Mar 13, 2026 | SEC |
| Nov 13, 202510:29 AM ET | Capital Research Global Investors | 13G/A | 3.30%1.03M shares | –Below 5% | Sep 30, 2025 | SEC |
| Aug 14, 20255:26 PM ET | Fuller & Thaler Asset Management, Inc. | 13G | 5.63%1.74M shares | New | Jun 30, 2025 | SEC |
| Jul 18, 202512:53 PM ET | BlackRock, Inc. | 13G/A | 15.10%4.68M shares | – | Jun 30, 2025 | SEC |
| Feb 13, 2024 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2024 | Earnest Partners LLC | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2024 | Capital Research Global Investors | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2023 | Capital Research Global Investors | 13GOld format | – | – | – | SEC |
| Feb 13, 2023 | Champlain Investment Partners, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2023 | Earnest Partners LLC | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2023 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Jan 26, 20238:52 AM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Jan 20, 20233:00 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Jul 11, 2022 | Earnest Partners LLC | 13G/AOld format | – | – | – | SEC |
| Mar 10, 2022 | Earnest Partners LLC | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Earnest Partners LLC | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2022 | Champlain Investment Partners, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2022 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Jan 27, 202211:00 AM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Jan 25, 20223:03 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Capital Research Global Investors | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Earnest Partners LLC | 13GOld format | – | New | – | SEC |
| Feb 12, 2021 | Champlain Investment Partners, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2021 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 5, 20217:51 AM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell CONMED Corp shares.
No Form 144 notices for CONMED Corp are on file.